Bill Gates pledges $30M for early Alzheimer’s research

Microsoft co-founder Bill Gates joined a handful of wealthy donors, July 17, saying he will pledge more than $30 million over three years to advance research aimed at early Alzheimer’s detection.

In a blog post on Gate’s website, he cited his father’s diagnosis with the disease as motivation behind Tuesday’s launch of the Diagnostics Accelerator program.

This venture follows his November 2017 announcement, when he pledged nearly $100 million to projects focused on researching dementia and Alzheimer’s disease.

“Imagine a world where diagnosing Alzheimer’s disease is as simple as getting your blood tested during your annual physical,” Gates wrote in the post. “Research suggests that future isn’t that far off, and Diagnostics Accelerator moves us one step closer.”

Read his entire blog post below:

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.